143 related articles for article (PubMed ID: 907355)
1. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
[No Abstract] [Full Text] [Related]
2. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
Basu A; Glew RH; Daniels LB; Clark LS
J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of the heat-stable glucocerebrosidase activator substance in Gaucher spleen.
Chiao YB; Chambers JP; Glew RH; Lee RE; Wenger DA
Arch Biochem Biophys; 1978 Feb; 186(1):42-51. PubMed ID: 629536
[No Abstract] [Full Text] [Related]
4. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
[TBL] [Abstract][Full Text] [Related]
5. Tissue acid hydrolase activities in Gaucher's disease.
Ockerman PA; Köhlin P
Scand J Clin Lab Invest; 1968; 22(1):62-4. PubMed ID: 5706652
[No Abstract] [Full Text] [Related]
6. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
[TBL] [Abstract][Full Text] [Related]
7. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
Peters SP; Coyle P; Coffee CJ; Glew RH
J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
[TBL] [Abstract][Full Text] [Related]
8. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
[TBL] [Abstract][Full Text] [Related]
9. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
Garrett KO; Prence EM; Glew RH
Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
[TBL] [Abstract][Full Text] [Related]
11. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
Salvayre R; Maret A; Negre A; Douste-Blazy L
Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
[No Abstract] [Full Text] [Related]
12. Characterization of lysosomal hydrolases that are elevated in Gaucher's disease.
Moffitt KD; Chambers JP; Diven WF; Glew RH; Wenger DA; Farrell DF
Arch Biochem Biophys; 1978 Sep; 190(1):247-60. PubMed ID: 101149
[No Abstract] [Full Text] [Related]
13. Multiple forms of beta-glucosidase in Gaucher disease.
Yaqoob M; Carroll M
Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
[No Abstract] [Full Text] [Related]
14. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.
Glew RH; Coffee CJ
Arch Biochem Biophys; 1984 Feb; 229(1):55-63. PubMed ID: 6422854
[TBL] [Abstract][Full Text] [Related]
16. Specificity of low molecular weight glycoprotein effector of lipid glycosidase.
Ho MW
FEBS Lett; 1975 May; 53(2):243-7. PubMed ID: 1140409
[No Abstract] [Full Text] [Related]
17. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
[TBL] [Abstract][Full Text] [Related]
18. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
Prence EM; Garrett KO; Glew RH
Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
[TBL] [Abstract][Full Text] [Related]
19. Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.
Pirruccello S; Barranger JA; Barton NW; Brady RO; Ginns EI
Biochem Med; 1984 Feb; 31(1):73-9. PubMed ID: 6743300
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of beta-glucocerebrosidase activity in the glucocerebroside-rich deposits of Gaucher's disease.
Glew RH; Christopher AR; Schnure FW; Lee RE
Arch Biochem Biophys; 1974 Jan; 160(1):162-7. PubMed ID: 4364062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
